170P Preliminary results from LUMINANCE: A phase IIIb, single-arm study of 1L durvalumab (D) + platinum-etoposide (EP) for patients with extensive-stage SCLC (ES-SCLC)
JOURNAL OF THORACIC ONCOLOGY（2023）
关键词
1l durvalumab,single-arm,platinum-etoposide,extensive-stage,es-sclc
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要